Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II

This publication has 32 references indexed in Scilit:

• Glycoprotein IIb/IIIa Receptor Inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG Trials into Perspective
  The American Journal of Cardiology, 1996
• Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention
  The American Journal of Cardiology, 1995
• Cell adhesion molecules in coronary artery disease
  Journal of the American College of Cardiology, 1994
• Predicting the risk of abrupt vessel closure after angioplasty in an individual patient
  Journal of the American College of Cardiology, 1994
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
  The Lancet, 1994
• Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty
  American Heart Journal, 1994
• Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Long-term outcome following successful reopening of abrupt closure after coronary angioplasty
  The American Journal of Cardiology, 1993
• Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
  The American Journal of Cardiology, 1987
• Integrins: A family of cell surface receptors
  Cell, 1987